Tiansheng Pharmaceutical Group Co Ltd (SHE:002872) — Market Cap & Net Worth
Market Cap & Net Worth: Tiansheng Pharmaceutical Group Co Ltd (002872)
Tiansheng Pharmaceutical Group Co Ltd (SHE:002872) has a market capitalization of $229.41 Million (CN¥1.57 Billion) as of June 19, 2026. Listed on the SHE stock exchange, this China-based company holds position #16097 globally and #4612 in its home market, demonstrating a -2.38% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Tiansheng Pharmaceutical Group Co Ltd's stock price CN¥4.93 by its total outstanding shares 318000000 (318.00 Million). Review Tiansheng Pharmaceutical Group Co Ltd debt and liabilities to assess the company's total debt and financial obligations.
Tiansheng Pharmaceutical Group Co Ltd Market Cap History: 2017 to 2026
Tiansheng Pharmaceutical Group Co Ltd's market capitalization history from 2017 to 2026. Data shows change from $934.55 Million to $229.41 Million (-14.82% CAGR).
Tiansheng Pharmaceutical Group Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Tiansheng Pharmaceutical Group Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.37x
Tiansheng Pharmaceutical Group Co Ltd's market cap is 0.37 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $934.55 Million | $2.26 Billion | $248.58 Million | 0.41x | 3.76x |
| 2018 | $398.33 Million | $2.17 Billion | $15.62 Million | 0.18x | 25.50x |
| 2019 | $249.88 Million | $1.68 Billion | -$218.94 Million | 0.15x | N/A |
| 2020 | $220.57 Million | $1.20 Billion | -$493.59 Million | 0.18x | N/A |
| 2021 | $242.90 Million | $736.69 Million | -$72.34 Million | 0.33x | N/A |
| 2022 | $245.70 Million | $606.99 Million | -$91.55 Million | 0.40x | N/A |
| 2023 | $238.72 Million | $579.33 Million | -$93.07 Million | 0.41x | N/A |
| 2024 | $211.26 Million | $569.71 Million | -$87.40 Million | 0.37x | N/A |
Competitor Companies of 002872 by Market Capitalization
Companies near Tiansheng Pharmaceutical Group Co Ltd in the global market cap rankings as of June 19, 2026.
Key companies related to Tiansheng Pharmaceutical Group Co Ltd by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #221 globally with a market cap of $110.45 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #445 globally with a market cap of $62.84 Billion USD.
- UCB SA (BR:UCB): Ranked #547 globally with a market cap of $49.68 Billion USD ( €42.50 Billion EUR).
- Argen-X (BR:ARGX): Ranked #573 globally with a market cap of $47.14 Billion USD ( €40.32 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #221 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $110.45 Billion | $451.63 |
| #445 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $62.84 Billion | $609.94 |
| #547 | UCB SA | BR:UCB | $49.68 Billion | €249.20 |
| #573 | Argen-X | BR:ARGX | $47.14 Billion | €762.80 |
Tiansheng Pharmaceutical Group Co Ltd Historical Marketcap From 2017 to 2026
Between 2017 and today, Tiansheng Pharmaceutical Group Co Ltd's market cap moved from $934.55 Million to $ 229.41 Million, with a yearly change of -14.82%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥229.41 Million | +1.44% |
| 2025 | CN¥226.15 Million | +7.05% |
| 2024 | CN¥211.26 Million | -11.50% |
| 2023 | CN¥238.72 Million | -2.84% |
| 2022 | CN¥245.70 Million | +1.15% |
| 2021 | CN¥242.90 Million | +10.13% |
| 2020 | CN¥220.57 Million | -11.73% |
| 2019 | CN¥249.88 Million | -37.27% |
| 2018 | CN¥398.33 Million | -57.38% |
| 2017 | CN¥934.55 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 19th, 2026 the market cap of Tiansheng Pharmaceutical Group Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $229.41 Million USD |
| MoneyControl | $229.41 Million USD |
| MarketWatch | $229.41 Million USD |
| marketcap.company | $229.41 Million USD |
| Reuters | $229.41 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Tiansheng Pharmaceutical Group Co Ltd
Tiansheng Pharmaceutical Group Co., Ltd. engages in the pharmaceutical manufacturing and circulation activities. It offers products in various categories, including respiratory, cardiovascular and cerebrovascular, urinary system, gynecological, orthopedic, cardiology, diabetes, anesthetic, and others. It also provides traditional Chinese medicines and glucose injection. The company was founded in… Read more